Adrian W R Serohijos, Shuangye Yin, Feng Ding, Josee Gauthier, Dustin G Gibson, William Maixner, Nikolay V Dokholyan, Luda Diatchenko
Index: Structure 19(11) , 1683-90, (2011)
Full Text: HTML
Opioids that stimulate the μ-opioid receptor (MOR1) are the most frequently prescribed and effective analgesics. Here we present a structural model of MOR1. Molecular dynamics simulations show a ligand-dependent increase in the conformational flexibility of the third intracellular loop that couples with the G protein complex. These simulations likewise identified residues that form frequent contacts with ligands. We validated the binding residues using site-directed mutagenesis coupled with radioligand binding and functional assays. The model was used to blindly screen a library of ∼1.2 million compounds. From the 34 compounds predicted to be strong binders, the top three candidates were examined using biochemical assays. One compound showed high efficacy and potency. Post hoc testing revealed this compound to be nalmefene, a potent clinically used antagonist, thus further validating the model. In summary, the MOR1 model provides a tool for elucidating the structural mechanism of ligand-initiated cell signaling and for screening novel analgesics.Copyright © 2011 Elsevier Ltd. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Nalmefene
CAS:55096-26-9 |
C21H25NO3 |
Treatment of alcohol dependence: recent progress and reducti...
2014-12-01 [Minerva Med. 105(6) , 447-66, (2014)] |
Pharmacotherapy for adults with alcohol use disorders in out...
2014-05-14 [JAMA 311(18) , 1889-900, (2014)] |
In vivo characterization of the opioid antagonist nalmefene ...
2010-04-10 [Life Sci. 86(15-16) , 624-30, (2010)] |
A randomized, double-blind, vehicle-controlled crossover stu...
2011-08-01 [Journal. of. Drugs in. Dermatology. 10(8) , 853-60, (2011)] |
Nalmefene and its use in alcohol dependence.
2014-05-01 [Drugs Today (Barc) 50(5) , 347-55, (2014)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved